Brain Metastases
The most common brain tumor. Radiosurgery offers a non-invasive alternative to whole-brain radiation or open surgery.
01 / 06
Radiosurgery-as-a-Service
World-class
radiosurgery.
Delivered.
Millions need access to life-saving radiosurgery but can't get it. Your hospital can change that. We remove every barrier — capital, equipment, operations, patients — so you can focus on what matters most.
$0
Capital required
0%
Clinical revenue retained
0–7 months
To go-live
The Reality
Millions of patients wait because the economics are broken.
Building a radiosurgery program today means $3.5M+ in equipment, 12-24 months of capital approval, radiation vaults, and 100% of the financial risk on your hospital. Most never start.
Your patients are waiting. We built Proxis to help you reach them.
We provide the capital, the equipment, the installation, the maintenance, and the program playbook — and in Latin America, the patient pipeline. You provide the facility and the clinical team. You retain full control — and all clinical revenue.
The Proxis Model
Everything you need. Nothing you don't.
You're the one bringing life-saving treatment to your community. We deploy every piece of the infrastructure — from capital to patients — so nothing stands in your way.
Capital
Equipment
Installation
Maintenance
Patients
Insurance
We fund it
Capital
We fund the entire program — equipment, deployment, and operations. Zero capital from your hospital.
We deploy it
Equipment
Self-shielded radiosurgery system — no vault required. We own and deploy the most advanced platform available.
We build it
Installation
Full site preparation, regulatory compliance, and system commissioning. Operational in 6–7 months.
We sustain it
Maintenance
Ongoing technical support, calibration, and system servicing. We keep it running at peak performance.
We power it
Growth
Referral development, digital patient acquisition, and navigation. Operated by Proxis in Latin America; delivered as playbooks and training to your team in the United States.
We prepare you
Billing & Insurance
Coding and reimbursement guides for radiosurgery in your market, plus insurance on the system. Your revenue cycle stays yours.
You bring the breakthrough to your community. You keep everything.
Two markets, two models
Same outcome everywhere: a radiosurgery program with zero capital. The structure fits the market.
In the United States, the program is delivered under an operating lease — your team runs it. In Latin America, Proxis runs the program with you.
United States
Operating lease + service & training
- One flat monthly fee. Five-year term. Renew, return, or buy at fair market value.
- Not a joint venture. Not a revenue share. No physician investors.
- We provide the system, service, insurance, training, billing guides, and program playbooks.
- Your team operates, navigates, markets, and bills. You keep 100% of revenue.
- Standard room, no vault. First patient in 6–7 months.
Latin America
Full program — we run it with you
- Choose at signing: a flat monthly fee, or a base fee plus volume with capital-recovery terms.
- Everything in the US model, plus marketing, patient acquisition, navigation, clinical governance, and program management.
- You provide the facility and clinical team. You keep 100% of clinical revenue.
- Standard room, no vault. First patient in 6–7 months.
- No regional exclusivity.
Conditions Treated
Precision treatment for complex conditions.
Stereotactic radiosurgery delivers sub-millimeter precision radiation in 1-5 outpatient sessions. Patients go home the same day.
Trigeminal Neuralgia
Severe facial pain treated with a single precise dose. 80%+ of patients experience significant relief.
Acoustic Neuromas
Benign tumors on the hearing nerve. Radiosurgery preserves hearing and facial function without open surgery.
Meningiomas
Tumors of the brain lining. Treated non-invasively with high tumor control rates and minimal side effects.
AVMs
Arteriovenous malformations — abnormal tangles of blood vessels. Radiosurgery gradually closes them without craniotomy.
Pituitary Adenomas
Tumors of the pituitary gland affecting hormones and vision. Precise treatment with minimal disruption.
Radiosurgery
Sessions1–5
SettingOutpatient
Return homeSame day
Traditional Radiation
Sessions10–40
SettingWeeks of daily visits
ImpactSignificant disruption
The Growth Engine
We don't just deploy equipment. We build the demand.
Most radiosurgery programs fail not because of clinical quality — but because of empty chairs. Proxis addresses this with a radiosurgery-specific growth engine: search visibility, referral development, and patient navigation. In Latin America, Proxis operates it as part of your program agreement. In the United States, Proxis provides the playbook, training, and tools — your team operates it.
01
Discover
AI-powered search optimization ensures patients and referring physicians find your program — across Google, LLMs, and social.
02
Navigate
Patient navigators convert inquiries into treated patients. No lead falls through the cracks. Operated by Proxis in Latin America; run by your team with our playbook in the United States.
03
Treat
Your clinical team delivers world-class care. We handle everything upstream so you can focus on what matters.
The Growth Engine starts months before your first patient — so demand is building on day one.
Your Guide
Built by operators who've done this before.
Our founding team has built and scaled radiosurgery programs generating hundreds of millions in revenue across the Americas. We've guided hospitals through every step — deployment, growth, and operations — so you're never doing this alone.
$0M+
Founders' combined revenue
0+
Systems deployed by our founders
0+
Countries
FAQ
Common questions.
Stereotactic radiosurgery (SRS) is a non-invasive treatment that delivers precisely targeted radiation to treat tumors and other conditions in the brain. Despite its name, it requires no incision. Patients typically go home the same day after 1-5 sessions, compared to 10-40 sessions with traditional radiation therapy.
Radiosurgery treats brain metastases, trigeminal neuralgia, acoustic neuromas, meningiomas, arteriovenous malformations (AVMs), pituitary adenomas, and other intracranial conditions. It is particularly effective for tumors that are difficult to reach with conventional surgery.
A self-shielded system contains its own radiation shielding within the device, eliminating the need for an expensive radiation vault or bunker. This dramatically reduces deployment cost, time, and facility requirements — allowing radiosurgery to be offered in standard outpatient clinical settings.
Proxis provides the capital, equipment, installation, maintenance, training, and program playbooks — and in Latin America, clinical governance and patient acquisition as well. Your hospital provides the facility and clinical team, retains 100% of clinical revenue, and maintains full program control. No upfront capital investment is required.
No. In the United States, the program is delivered under a five-year operating lease of the radiosurgery system plus a service and training agreement — one flat monthly fee. No shared ownership, no percentage of collections, no physician investors. Your hospital owns the program and keeps 100% of clinical revenue. In Latin America, hospitals choose at signing between a flat monthly fee and a base-plus-volume structure; either way the hospital keeps 100% of clinical revenue.
Proxis works with hospitals across the Americas, including the United States, Mexico, Central America, and South America. Our founders have deployed radiosurgery systems in 15+ countries over their careers; Proxis is now deploying its first programs in Mexico, Central America, and the United States. We evaluate each market for patient demand, reimbursement viability, and regulatory readiness before entering.
Let's Talk
Ready to bring radiosurgery to your community?
Tell us about your program and we'll walk you through how Proxis works — including the economics, timeline, and clinical support.
Or email us directly at partners@proxis.health